Riskpilot← Back to searchSign inGet full accessOrtoRad AB
ABActiveOrg 5592530033Granåsvägen 19 BGeneral medical practice activities · NACE 8621Est. 20200 employees
Revenue 2024
SEK 310K
+37% vs 2023
EBITDA margin
40.5%
-23% vs 2023
Equity ratio
75.3%
Financial strength
Net profit 2024
SEK 99K
-22% vs 2023
| Revenue | SEK 310K | +37% |
| EBITDA | SEK 126K | -23% |
| Net profit | SEK 99K | -22% |
| Total assets | SEK 551K | +7% |
| Equity | SEK 415K | +24% |
| Employees | 0 | — |
Legal name
OrtoRad AB
Org number
5592530033
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
22 april 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet inom hälso- och sjukvård. Primärvård, ortopedisk samt estetisk kirurgi. Radiologi. Handel med medicintekniska produkter samt läkemedel. Bedriva handel med värdepapper.
Address
Granåsvägen 19 B
Email
ortoradab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 54 | 132 | 305 | 226 | 310 |
| Staff expenses | — | — | — | −5 | −18 |
| EBITDA | 29 | 115 | 278 | 163 | 126 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 29 | 115 | 278 | 163 | 126 |
| Net financials | −1 | — | — | 0 | 0 |
| Profit before tax | 28 | 88 | 228 | 161 | 126 |
| Tax | −6 | −19 | −46 | −34 | −27 |
| Net profit | 22 | 69 | 182 | 128 | 99 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 218 | 340 | 583 | 513 | 551 |
| Equity | 47 | 116 | 298 | 335 | 415 |
| Long-term debt | 150 | 140 | 0 | — | — |
| Short-term debt | 21 | 56 | 208 | 98 | 56 |
| Total debt | 171 | 196 | 208 | 98 | 56 |
EBITDA margin
40.5%
This company
15.8%
Market median
+156% vs market
20202024
Equity ratio
75.3%
This company
38.2%
Market median
+97% vs market
20202024
Return on equity
24.0%
This company
18.4%
Market median
+30% vs market
20202024
Net profit margin
32.0%
This company
8.1%
Market median
+295% vs market
20202024
Asset turnover
0.56×
This company
1.12×
Market median
-50% vs market
20202024
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-04-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JE Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
NJ Chief Executive Officer | Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OrtoRad AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jenny Eva Charlotte Hallsten | Deputy Chief Executive Officer | 0 companies |
| Nils Jesper Hallsten | Chief Executive Officer | 0 companies |